” content_phone=”<\/p>\n
Healthcare Professionals Hub<\/span><\/a><\/p>\n ” content_last_edited=”on|phone” admin_label=”Text” _builder_version=”4.27.2″ _module_preset=”default” text_font=”|700|||||||” text_text_color=”#ea5504″ text_orientation=”center” custom_margin=”||||false|false” custom_margin_tablet=”” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”||||false|false” link_option_url_new_window=”on” text_text_color_tablet=”” text_text_color_phone=”” text_text_color_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n Healthcare Professionals Hub<\/span><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ admin_label=”Column” _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_3″ admin_label=”Column” _builder_version=”4.24.0″ _module_preset=”default” background_color_phone=”RGBA(255,255,255,0)” background_last_edited=”on|phone” background_enable_color_phone=”on” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.2″ _module_preset=”default” text_font=”|700|||||||” text_text_color=”#FFFFFF” background_color=”#ea5504″ width=”100%” module_alignment=”center” custom_margin=”||||false|false” custom_margin_tablet=”” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|desktop” custom_padding=”10px||||false|false” link_option_url=”https:\/\/kyowakirininternational.com\/global-reporting\/” link_option_url_new_window=”on” border_color_all=”#FFFFFF” global_colors_info=”{}”]<\/p>\n Report Adverse Event [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” z_index=”500″ width=”100%” max_width=”100%” min_height=”100px” height=”100px” overflow-x=”visible” overflow-y=”visible” custom_margin=”||||false|false” custom_padding=”|||25px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”37″ active_link_color=”#ea5504″ dropdown_menu_bg_color=”#5d6164″ dropdown_menu_line_color=”#ff3300″ dropdown_menu_text_color=”#000000″ dropdown_menu_active_link_color=”#ff3300″ mobile_menu_bg_color=”#b4c0c1″ mobile_menu_text_color=”#000000″ logo=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/01\/KyowaKirin_BrandLogo_colorv2-PhotoRoom-1-1024×216.png” logo_url=”https:\/\/kyowakirininternational.com\/noba-en\/” logo_width=”100%” logo_max_width=”17%” show_search_icon=”on” search_icon_color=”#ea5504″ menu_icon_color=”#ea5504″ logo_max_width_tablet=”35%” logo_max_width_phone=”76%” logo_max_width_last_edited=”on|phone” show_search_icon_tablet=”on” show_search_icon_phone=”on” show_search_icon_last_edited=”on|phone” search_icon_color_tablet=”#ea5504″ search_icon_color_phone=”#ea5504″ search_icon_color_last_edited=”on|phone” _builder_version=”4.25.1″ _module_preset=”default” menu_font=”|600|||||||” menu_text_color=”#5d6164″ menu_font_size=”17px” background_color=”RGBA(255,255,255,0)” custom_css_free_form=”.et_pb_menu__icon.et_pb_menu__search-button {||padding: 2% 2% 2% 1%;||||}” global_colors_info=”{}”][\/et_pb_menu][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” width=”90%” max_width=”100%” custom_margin=”-25px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][lwp_divi_breadcrumbs font_icon=”5||divi||400″ link_color=”#5d6164″ separator_color=”#e95505″ current_text_color=”#e95505″ _builder_version=”4.24.0″ _module_preset=”default” module_text_align=”left” background_color=”RGBA(255,255,255,0)” text_orientation=”left” animation_style=”fade” global_module=”1047″ global_colors_info=”{}”][\/lwp_divi_breadcrumbs][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.0″ _module_preset=”default” background_color=”#5d6164″ height=”50px” height_tablet=”100px” height_phone=”140px” height_last_edited=”on|phone” custom_margin=”||||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.25.1″ _module_preset=”default” custom_margin=”-40px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”40″ menu_style=”centered” active_link_color=”#ea5504″ dropdown_menu_line_color=”#ea5504″ dropdown_menu_active_link_color=”#ea5504″ mobile_menu_bg_color=”#b4c0c1″ mobile_menu_text_color=”#000000″ menu_icon_color=”#ea5504″ _builder_version=”4.25.1″ _module_preset=”default” menu_text_color=”#FFFFFF” menu_font_size=”15px” background_color=”RGBA(255,255,255,0)” global_colors_info=”{}”][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ prev_background_color=”#5d6164″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”#e5e5e5″ background_image=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/03\/MicroscopeCloseUp-1-1024×341.png” height=”564px” top_divider_style=”curve” top_divider_flip=”vertical” global_colors_info=”{}”][\/et_pb_section][et_pb_section fb_built=”1″ next_background_color=”#cccccc” module_id=”focus” _builder_version=”4.24.2″ _module_preset=”default” background_color=”#e5e5e5″ bottom_divider_style=”slant2″ bottom_divider_height=”40px” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.26.0″ _module_preset=”default” header_2_font=”|700|||||||” header_2_text_color=”#ea5504″ global_colors_info=”{}”]<\/p>\n We focus on innovation with the greatest potential to help patients with high unmet medical needs in bone and mineral diseases, intractable haematological diseases and haemato-oncology, and rare disease.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.25.1″ _module_preset=”default” animation_style=”slide” link_option_url=”https:\/\/kyowakirininternational.com\/noba-en\/what-we-do\/areas-of-focus\/” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Bone and Mineral Diseases” image=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/05\/Bone-and-Mineral-300×225-1.png” alt=”Rare Metabolic Diseases” image_icon_width=”100%” _builder_version=”4.25.1″ _module_preset=”default” header_font=”|700|||||||” header_text_align=”center” header_text_color=”#ea5504″ border_radii_image=”on|10px|10px|10px|10px” global_colors_info=”{}”]<\/p>\n Many bone and mineral diseases remain underdiagnosed, with a lack of treatment often leading to problems with growth and development. At Kyowa Kirin International, we have a long history of treating bone and mineral diseases, particularly related to metabolic disorders.<\/p>\n [\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Intractable Haematological Diseases and Haemato-Oncology ” image=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/05\/Hematology-Oncology-300×200-1.png” alt=”Haemato-Oncology” image_icon_width=”100%” _builder_version=”4.26.0″ _module_preset=”default” header_font=”|700|||||||” header_text_align=”center” header_text_color=”#ea5504″ border_radii_image=”on|10px|10px|10px|10px” global_colors_info=”{}”]<\/p>\n We strive to develop new treatments and solutions for patients living with diseases and cancers affecting blood and blood-forming organs, bone marrow and related tissues.<\/p>\n [\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Rare Diseases” image=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/05\/Rare-diseases-1.png” alt=”Rare Diseases” image_icon_width=”100%” _builder_version=”4.25.1″ _module_preset=”default” header_font=”|700|||||||” header_text_align=”center” header_text_color=”#ea5504″ border_radii_image=”on|10px|10px|10px|10px” global_colors_info=”{}”]<\/p>\n Rare diseases often go long undiagnosed and overlooked due to the small number of people living with them. At Kyowa Kirin International, however, we are committed to finding novel treatments to better the lives of patients living with rare diseases and make them smile.<\/p>\n [\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”focus” _builder_version=”4.25.0″ _module_preset=”default” background_color=”#cccccc” bottom_divider_height=”40px” animation_style=”slide” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.0″ _module_preset=”default” header_2_font=”|700|||||||” header_2_text_color=”#ea5504″ global_colors_info=”{}”]<\/p>\n We are passionate about using new technologies to develop novel and innovative solutions for some of the world\u2019s rarest diseases.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.25.1″ _module_preset=”default” animation_style=”slide” link_option_url=”https:\/\/kyowakirininternational.com\/noba-en\/what-we-do\/areas-of-focus\/” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Advanced Antibody Technology” image=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/05\/Advanced-Antibody-Technology-300×175.png” alt=”Rare Diseases” image_icon_width=”100%” _builder_version=”4.25.1″ _module_preset=”default” header_font=”|700|||||||” header_text_align=”center” header_text_color=”#ea5504″ border_radii_image=”on|10px|10px|10px|10px” global_colors_info=”{}”]<\/p>\n Kyowa Kirin has a number of high-quality foundational technologies that can be used to efficiently create therapeutic antibodies. We are leveraging our expertise in protein and antibody engineering technologies that we have developed over decades.<\/p>\n In addition, we focus on R&D investment for sustainable growth and to ensure we are bringing more value to patients in need. We are also actively engaged in collaborative research with research institutions to advance next-generation therapeutic antibodies, such as immunostimulatory antibodies and tissue-directed antibodies.<\/p>\n [\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Haematopoietic Stem Cell Gene Therapies” image=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/05\/gene-therapy-1.jpg” alt=”Haemato-Oncology” image_icon_width=”58%” _builder_version=”4.25.1″ _module_preset=”default” header_font=”|700|||||||” header_text_align=”center” header_text_color=”#ea5504″ border_radii_image=”on|10px|10px|10px|10px” global_colors_info=”{}”]<\/p>\n Building on decades of research and advancements in the field of gene therapy, we are working to develop potential cures for genetic and other severe diseases using haematopoietic stem cell gene therapy (HSC-GT).<\/p>\n Our approach harnesses the unique power of a patient\u2019s own genetically modified blood stem cells, also known as haematopoietic stem cells, or HSCs, to potentially correct the underlying cause of a genetic disease permanently using a single administration.<\/p>\n Furthermore, we are also developing new treatments by combining HSC-GT with the drug discovery technologies and expertise that Kyowa Kirin has cultivated over decades.<\/p>\n [\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.25.0″ _module_preset=”default” background_color=”#FFFFFF” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.2″ _module_preset=”default” link_option_url=”https:\/\/kyowakirininternational.com\/noba-en\/what-we-do\/supporting-patients\/” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” header_2_font=”|700|||||||” header_2_text_color=”#ea5504″ global_colors_info=”{}”]<\/p>\n <\/p>\n Patients are at the very heart of everything we do. We work to be a voice for patients among all stakeholders, ensuring their needs are heard during all stages of the medicine development continuum. We do this through strong partnerships with key Patient Advocacy Groups (PAGs), and championing disease awareness and treatment approach campaigns to drive best practice for patients.<\/p>\n We are also expanding geographically into Eastern Europe, Africa and Latin America, enabling us to meet the needs of more people across our region.<\/p>\n To find out more about how we are supporting patients, visit our Supporting Patients section here<\/a>.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Section” _builder_version=”4.24.2″ _module_preset=”default” background_color=”#5d6164″ custom_margin=”||||false|false” top_divider_style=”curve” top_divider_color=”#FFFFFF” top_divider_height=”71px” top_divider_repeat=”1x” top_divider_flip=”vertical” top_divider_style_tablet=”” top_divider_style_phone=”none” top_divider_style_last_edited=”on|desktop” global_module=”3452″ saved_tabs=”all” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” width=”70%” max_width=”100%” custom_margin=”-50px||||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/01\/KKI-Logo-White-PhotoRoom-1-300×86.png” title_text=”KKI Logo White-PhotoRoom” align=”center” _builder_version=”4.24.0″ _module_preset=”default” width=”200px” width_tablet=”15%” width_phone=”50%” width_last_edited=”on|phone” module_alignment=”center” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_6,1_6,1_6″ _builder_version=”4.24.0″ _module_preset=”default” width=”70%” max_width=”100%” custom_padding=”||27px|||” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#FFFFFF” header_4_text_color=”#FFFFFF” width=”100%” max_width=”100%” custom_padding=”5px|10px|5px|10px|false|false” border_width_all=”1px” border_color_all=”#FFFFFF” global_colors_info=”{}”]<\/p>\n ADVERSE EVENTS SHOULD BE REPORTED HERE<\/a><\/span><\/p>\n [\/et_pb_text][et_pb_text content_tablet=”” content_phone=”” content_last_edited=”on|phone” module_class=”my-popup2″ _builder_version=”4.25.1″ _module_preset=”default” text_font=”||||||||” text_text_color=”#E02B20″ text_orientation=”center” custom_margin=”||||false|false” custom_margin_tablet=”” custom_margin_phone=”-50px||||false|false” custom_margin_last_edited=”on|desktop” custom_padding=”||||false|false” text_font_size_tablet=”” text_font_size_phone=”” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n Click here to search for Kyowa Kirin\u2019s clinical trials<\/a><\/span><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” text_font=”||||||||” text_text_color=”#FFFFFF” text_font_size=”16px” global_colors_info=”{}”]<\/p>\n Press & Media<\/a><\/span> [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.2″ _module_preset=”default” text_text_color=”#FFFFFF” text_font_size=”16px” text_text_color_tablet=”” text_text_color_phone=”” text_text_color_last_edited=”on|desktop” global_colors_info=”{}” text_text_color__hover_enabled=”on|desktop” text_text_color__hover=”#FFFFFF”]<\/p>\n Reporting<\/a><\/span> [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” width=”70%” max_width=”100%” custom_padding=”||27px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.2″ _module_preset=”default” text_text_color=”#FFFFFF” header_text_color=”#FFFFFF” header_4_text_color=”#FFFFFF” header_6_text_color=”#FFFFFF” width=”100%” max_width=”100%” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” width=”70%” max_width=”100%” custom_margin=”-50px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.2″ _module_preset=”default” text_text_color=”#FFFFFF” width=”100%” max_width=”100%” global_colors_info=”{}”]<\/p>\n Copyright \u00a9 Kyowa Kirin International plc. All rights reserved. This website is developed and funded by Kyowa Kirin International plc.<\/span><\/p>\n Head Office Nordics & Baltics: Kyowa Kirin International plc is a company registered in Scotland (company number SC198780) with registered address at Galabank Business Park, Galashiels TD1 1QH, United Kingdom.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.2″ _module_preset=”default” background_color=”#5d6164″ global_colors_info=”{}”][et_pb_row _builder_version=”4.27.2″ _module_preset=”default” width=”70%” max_width=”100%” custom_margin=”-100px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#FFFFFF” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]KKI\/NORD\/KKI\/0043 April 2025[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Learn more about our specialty medicine portfolio which, encompasses the following therapy areas<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":26,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-888","page","type-page","status-publish","hentry"],"yoast_head":"\n![\"\"](\"https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/01\/Link-to-external-1.png\")
<\/p>\nOur Areas of Focus<\/h2>\n
Leveraging Innovative Modalities for Drug Discovery and Novel Therapies <\/h2>\n
Supporting Patients<\/h2>\n
Careers<\/a><\/span><\/p>\n
Responsibility<\/a><\/span><\/p>\nABOUT US<\/a>\u00a0 |\u00a0 CONTACT US<\/a>\u00a0 |\u00a0 NOTICES<\/a>\u00a0 |\u00a0 TERMS OF USE<\/a><\/h4>\n
MODERN SLAVERY ACT<\/a> | THIRD PARTY CODE OF CONDUCT<\/a><\/h4>\n
Kyowa Kirin AB
Torshamnsgatan 39
164 40 Kista
Sweden
Tel: + 46 (8) 50 90 74 10<\/p>\n